Gene and pathway based burden analyses in familial lymphoid cancer cases: Rare variants in immune pathway genes

PLoS One. 2023 Jun 28;18(6):e0287602. doi: 10.1371/journal.pone.0287602. eCollection 2023.

Abstract

Genome-wide association studies have revealed common genetic variants with small effect sizes associated with diverse lymphoid cancers. Family studies have uncovered rare variants with high effect sizes. However, these variants explain only a portion of the heritability of these cancers. Some of the missing heritability may be attributable to rare variants with small effect sizes. We aim to identify rare germline variants associated with familial lymphoid cancers using exome sequencing. One case per family was selected from 39 lymphoid cancer families based on early onset of disease or rarity of subtype. Control data was from Non-Finnish Europeans in gnomAD exomes (N = 56,885) or ExAC (N = 33,370). Gene and pathway-based burden tests for rare variants were performed using TRAPD. Five putatively pathogenic germline variants were found in four genes: INTU, PEX7, EHHADH, and ASXL1. Pathway-based association tests identified the innate and adaptive immune systems, peroxisomal pathway and olfactory receptor pathway as associated with lymphoid cancers in familial cases. Our results suggest that rare inherited defects in the genes involved in immune system and peroxisomal pathway may predispose individuals to lymphoid cancers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Exome Sequencing
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study*
  • Germ-Line Mutation
  • Humans
  • Neoplasms*

Grants and funding

The Canadian Institutes for Health Research (MOP-130311) and the BC Cancer Foundation Research Sustainment Fund, provided to Dr. Angela Brooks-Wilson, funded this work. PhD student Sneha Ralli was also supported by Graduate Fellowships from Simon Fraser University, and through an NSERC-CREATE grant for Bioinformatics training held jointly by Simon Fraser University and the University of British Columbia.